Work

Analysis of Predictive Factors in a Phase 3 Trial of Nab-Paclitaxel (nab-P) Plus Carboplatin (C) as First-Line Therapy for Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC)

Year: 2014

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2014.08.228

Authors: V. Hirsh, R.D. Page, A. Ko, M. Renshler, M.A. Socinski

Institutions: McGill University, Center for Cancer and Blood Disorders, Celgene (United States), University of Pittsburgh

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2094092704

FWCI: 0.267

Cites:

Cited by: 1

Related to: 10